Skip to main content
. 2021 Oct 12;2021(10):CD011589. doi: 10.1002/14651858.CD011589.pub2

Girgis 2009.

Study characteristics
Methods Randomised trial, Australia
Participants 356 patients with non‐localised breast or colorectal cancer within 6 months of diagnosis
Usual care mean age 57.4 years female 71.8%
O/GP mean age 58.3 years female 72.3%
TCW mean age 57.8 years female 72.5%
Interventions Feedback of PROs via either a telephone caseworker or a oncologist/GP
Anxiety and depression (HADS)
Quality of Life (EORTC version 3)
Perceived needs (Suportive Needs Survey‐Short Form)
 
Intervention features
Multiple complex feedback (multiple PROMs at multiple times) 
PROM(s) used as intervention: European Organisation for Research and Treatment of Cancer (EORTC QLQ‐C30), 34‐item Supportive Needs Survey‐SF (perceived needs), 10 items from the Needs Assessment for Advanced Cancer Patients Questionnaire (other prevalent needs)
Constructs measured: Health related Quality of Life, Symptoms, Functioning
Instrument categories/domains: Domain/Disease specific (cancer)
 
Administration features
Where PROMs administered: Non‐clinical setting
How administered: Interviewer‐administered
Format of PROMs questionnaire(s): Electronic
 
Feedback features
Format of PROMs feedback: Electronic, Paper
How often information fed back: 3 times (baseline, 3 months, and 6 months)
Who information fed back to: Clinicians
Information fed back: Scores, Interpretation guidance, Management recommendations
Outcomes Main outcome: impact of supportive care models
Other outcomes: anxiety and depression (HADS), quality of Life (EORTC version 3), perceived needs (Suportive Needs Survey‐Short Form). The study period is not reported. The authors declare no conflicts of interest. 
Notes The study was funded by National Health and Medical Research Council of Australia Palliative Care Research (grant# 300807; Medical Benefits Fund of Australia; Hunter Medical Research Institute (infrastructure support); Afaf Girgis
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Low risk Randomisation performed quote: "using a computer‐generated algorithm".
Allocation concealment (selection bias) Low risk Computer‐generated randomisation at baseline
Blinding of participants and personnel (performance bias)
All outcomes High risk Due to nature of intervention not possible to blind patients and personnel.
Blinding of outcome assessment (detection bias)
All outcomes High risk Due to nature of the intervention blinding of outcomes not possible: PROM used for feedback also used to assess outcome, patients were aware they received the intervention.
Baseline outcome measurements similar Unclear risk No baseline outcome scores provided ‐ only at T2 and T3 in table 1
Baseline characteristics similar Low risk Paper states quote: "All groups had similar baseline demographic and clinical characteristics" (table provided).
Incomplete outcome data (attrition bias)
All outcomes Unclear risk Not reported
Was study protected against contamination Unclear risk GPs and oncologists nominated by control groups participants but intervention participants allocated case workers ‐ unclear as to whether either group could have had access to the other information
Selective reporting (reporting bias) Unclear risk Unclear whether selective reporting took place